메뉴 건너뛰기




Volumn 71, Issue , 2013, Pages S20-S28

Efficacy and safety of methotrexate in combination with other Non-Biologic diseasemodifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR;

EID: 84888332089     PISSN: 23284633     EISSN: 23285273     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (13)

References (41)
  • 1
    • 84859832981 scopus 로고    scopus 로고
    • 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
    • May
    • Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641.
    • (2012) Arthritis Care Res (Hoboken) , vol.64 , Issue.5 , pp. 625-639
    • Singh, J.A.1    Furst, D.E.2    Bharat, A.3
  • 2
    • 77953696525 scopus 로고    scopus 로고
    • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
    • Jun, Epub 2010 May 5
    • Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010 Jun;69(6):964-75. doi: 10.1136/ard.2009.126532. Epub 2010 May 5.
    • (2010) Ann Rheum Dis , vol.69 , Issue.6 , pp. 964-975
    • Smolen, J.S.1    Landewé, R.2    Breedveld, F.C.3
  • 3
    • 34347388745 scopus 로고    scopus 로고
    • QUEST-RA: Quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries
    • Nov, Epub 2007 Apr 5
    • Sokka T, Kautiainen H, Toloza S, et al. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis. 2007 Nov;66(11):1491-6. Epub 2007 Apr 5.
    • (2007) Ann Rheum Dis , vol.66 , Issue.11 , pp. 1491-1496
    • Sokka, T.1    Kautiainen, H.2    Toloza, S.3
  • 4
    • 0142124934 scopus 로고    scopus 로고
    • Methotrexate as the “anchor drug” for the treatment of early rheumatoid arthritis
    • Sep-Oct
    • Pincus T, Yazici Y, Sokka T, et al. Methotrexate as the “anchor drug” for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S179-85.
    • (2003) Clin Exp Rheumatol , vol.21 , Issue.5 , pp. S179-S185
    • Pincus, T.1    Yazici, Y.2    Sokka, T.3
  • 5
    • 67549096874 scopus 로고    scopus 로고
    • Multinational evidence- based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: Integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
    • Jul, Epub 2008 Nov 25
    • Visser K, Katchamart W, Loza E, et al. Multinational evidence- based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis. 2009 Jul;68(7):1086-93. doi: 10.1136/ard.2008.094474. Epub 2008 Nov 25.
    • (2009) Ann Rheum Dis , vol.68 , Issue.7 , pp. 1086-1093
    • Visser, K.1    Katchamart, W.2    Loza, E.3
  • 6
    • 0142135697 scopus 로고    scopus 로고
    • Direct medical costs and their predictors in patients with rheumatoid arthritis: A three-year study of 7,527 patients
    • Oct
    • Michaud K, Messer J, Choi HK, Wolfe F. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis Rheum. 2003 Oct;48(10):2750-62.
    • (2003) Arthritis Rheum , vol.48 , Issue.10 , pp. 2750-2762
    • Michaud, K.1    Messer, J.2    Choi, H.K.3    Wolfe, F.4
  • 7
    • 0029914622 scopus 로고    scopus 로고
    • Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
    • Feb
    • Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996 Feb;17(1):1-12.
    • (1996) Control Clin Trials , vol.17 , Issue.1 , pp. 1-12
    • Jadad, A.R.1    Moore, R.A.2    Carroll, D.3
  • 8
    • 0023945481 scopus 로고
    • The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
    • Mar
    • Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315-24.
    • (1988) Arthritis Rheum , vol.31 , Issue.3 , pp. 315-324
    • Arnett, F.C.1    Edworthy, S.M.2    Bloch, D.A.3
  • 9
    • 0029022389 scopus 로고
    • Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group
    • Jul 20
    • Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med. 1995 Jul 20;333(3):137-41.
    • (1995) N Engl J Med , vol.333 , Issue.3 , pp. 137-141
    • Tugwell, P.1    Pincus, T.2    Yocum, D.3
  • 10
    • 0037976830 scopus 로고    scopus 로고
    • Add-on or step-up trials for new drug development in rheumatoid arthritis: A new standard?
    • Jun
    • Boers M. Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard? Arthritis Rheum. 2003 Jun;48(6):1481-3.
    • (2003) Arthritis Rheum , vol.48 , Issue.6 , pp. 1481-1483
    • Boers, M.1
  • 11
    • 0033869333 scopus 로고    scopus 로고
    • Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone
    • Aug
    • Proudman SM, Conaghan PG, Richardson C, et al. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum. 2000 Aug;43(8):1809-19.
    • (2000) Arthritis Rheum , vol.43 , Issue.8 , pp. 1809-1819
    • Proudman, S.M.1    Conaghan, P.G.2    Richardson, C.3
  • 12
    • 0344237251 scopus 로고    scopus 로고
    • Radiographic progression in early rheumatoid arthritis: A 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone
    • Dec, Epub 2003 Jun 16
    • Marchesoni A, Battafarano N, Arreghini M, et al. Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone. Rheumatology (Oxford). 2003 Dec;42(12):1545-9. Epub 2003 Jun 16.
    • (2003) Rheumatology (Oxford) , vol.42 , Issue.12 , pp. 1545-1549
    • Marchesoni, A.1    Battafarano, N.2    Arreghini, M.3
  • 13
    • 0037377961 scopus 로고    scopus 로고
    • Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: A double blind randomised placebo controlled trial
    • Apr
    • Gerards AH, Landewé RB, Prins AP, et al. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial. Ann Rheum Dis. 2003 Apr;62(4):291-6.
    • (2003) Ann Rheum Dis , vol.62 , Issue.4 , pp. 291-296
    • Gerards, A.H.1    Landewé, R.B.2    Prins, A.P.3
  • 14
    • 45149113632 scopus 로고    scopus 로고
    • Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: Second-year clinical and radiographic results from the CIMESTRA study
    • Jun, Epub 2007 Sep 18
    • Hetland ML, Stengaard-Pedersen K, Junker P, et al. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis. 2008 Jun;67(6):815-22. Epub 2007 Sep 18.
    • (2008) Ann Rheum Dis , vol.67 , Issue.6 , pp. 815-822
    • Hetland, M.L.1    Stengaard-Pedersen, K.2    Junker, P.3
  • 15
    • 42449088470 scopus 로고    scopus 로고
    • Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis
    • May, Epub 2007 Sep 3
    • Choy EH, Smith CM, Farewell V, et al. Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis. Ann Rheum Dis. 2008 May;67(5):656-63. Epub 2007 Sep 3.
    • (2008) Ann Rheum Dis , vol.67 , Issue.5 , pp. 656-663
    • Choy, E.H.1    Smith, C.M.2    Farewell, V.3
  • 16
    • 15144356729 scopus 로고    scopus 로고
    • Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: An open-label extension study. The Methotrexate-Cyclosporine Combination Study Group
    • Oct
    • Stein CM, Pincus T, Yocum D, et al. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group. Arthritis Rheum. 1997 Oct;40(10):1843-51.
    • (1997) Arthritis Rheum , vol.40 , Issue.10 , pp. 1843-1851
    • Stein, C.M.1    Pincus, T.2    Yocum, D.3
  • 17
    • 9244247260 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications
    • May 16
    • O’Dell JR, Haire CE, Erikson N, et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med. 1996 May 16;334(20):1287-91.
    • (1996) N Engl J Med , vol.334 , Issue.20 , pp. 1287-1291
    • O’Dell, J.R.1    Haire, C.E.2    Erikson, N.3
  • 18
    • 0030696346 scopus 로고    scopus 로고
    • Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: A randomized, controlled, double-blind, 52 week clinical trial
    • Oct
    • Haagsma CJ, van Riel PL, de Jong AJ, van de Putte LB. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol. 1997 Oct;36(10):1082-8.
    • (1997) Br J Rheumatol , vol.36 , Issue.10 , pp. 1082-1088
    • Haagsma, C.J.1    Van Riel, P.L.2    De Jong, A.J.3    Van De Putte, L.B.4
  • 19
    • 0030751946 scopus 로고    scopus 로고
    • Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
    • Aug
    • Boers M, Verhoeven AC, Markusse HM, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet. 1997 Aug 2;350(9074):309-18.
    • (1997) Lancet , vol.350 , Issue.9074 , pp. 309-318
    • Boers, M.1    Verhoeven, A.C.2    Markusse, H.M.3
  • 20
    • 0036166382 scopus 로고    scopus 로고
    • COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention
    • Feb
    • Landewe RB, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum. 2002 Feb;46(2):347-56.
    • (2002) Arthritis Rheum , vol.46 , Issue.2 , pp. 347-356
    • Landewe, R.B.1    Boers, M.2    Verhoeven, A.C.3
  • 21
    • 0033535754 scopus 로고    scopus 로고
    • Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial. FIN-RACo trial group
    • May
    • Möttönen T, Hannonen P, Leirisalo-Repo M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet. 1999 May;353(9164):1568-73.
    • (1999) Lancet , vol.353 , Issue.9164 , pp. 1568-1573
    • Möttönen, T.1    Hannonen, P.2    Leirisalo-Repo, M.3
  • 22
    • 0344286554 scopus 로고    scopus 로고
    • Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis
    • Nov-Dec
    • Calguneri M, Pay S, Calişkaner Z, et al. Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis. Clin Exp Rheumatol. 1999 Nov-Dec; 17(6): 699-704.
    • (1999) Clin Exp Rheumatol , vol.17 , Issue.6 , pp. 699-704
    • Calguneri, M.1    Pay, S.2    Calişkaner, Z.3
  • 23
    • 0032957015 scopus 로고    scopus 로고
    • Combination therapy in early rheumatoid arthritis: A randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components
    • Apr
    • Dougados M, Combe B, Cantagrel A, et al. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis. 1999 Apr;58(4):220-5.
    • (1999) Ann Rheum Dis , vol.58 , Issue.4 , pp. 220-225
    • Dougados, M.1    Combe, B.2    Cantagrel, A.3
  • 24
    • 0036096084 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: Results of a two-year, randomized, double- blind, placebo-controlled trial
    • May
    • O’Dell JR, Leff R, Paulsen G, et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double- blind, placebo-controlled trial. Arthritis Rheum. 2002 May;46(5):1164-70.
    • (2002) Arthritis Rheum , vol.46 , Issue.5 , pp. 1164-1170
    • O’Dell, J.R.1    Leff, R.2    Paulsen, G.3
  • 25
    • 0037027427 scopus 로고    scopus 로고
    • Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial
    • Nov 5
    • Kremer JM, Genovese MC, Cannon GW, et al. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2002 Nov 5;137(9):726-33.
    • (2002) Ann Intern Med , vol.137 , Issue.9 , pp. 726-733
    • Kremer, J.M.1    Genovese, M.C.2    Cannon, G.W.3
  • 26
    • 33646479007 scopus 로고    scopus 로고
    • Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis
    • May
    • Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum. 2006 May;54(5):1435-9.
    • (2006) Arthritis Rheum , vol.54 , Issue.5 , pp. 1435-1439
    • Suissa, S.1    Hudson, M.2    Ernst, P.3
  • 27
    • 73449096104 scopus 로고    scopus 로고
    • Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide
    • Jan
    • Curtis JR, Beukelman T, Onofrei A, et al. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide. Ann Rheum Dis. 2010 Jan;69(1):43-7.
    • (2010) Ann Rheum Dis , vol.69 , Issue.1 , pp. 43-47
    • Curtis, J.R.1    Beukelman, T.2    Onofrei, A.3
  • 28
    • 0032745849 scopus 로고    scopus 로고
    • Combination DMARD treatment with parenteral gold and methotrexate
    • Nov-Dec
    • Rau R. Combination DMARD treatment with parenteral gold and methotrexate. Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S83-90.
    • (1999) Clin Exp Rheumatol , vol.17 , Issue.6 , pp. S83-S90
    • Rau, R.1
  • 29
    • 0030805502 scopus 로고    scopus 로고
    • Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients
    • Elkayam O, Yaron M, Zhukovsky G, et al. Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients. Rheumatol Int. 1997;17(2):49-53.
    • (1997) Rheumatol Int , vol.17 , Issue.2 , pp. 49-53
    • Elkayam, O.1    Yaron, M.2    Zhukovsky, G.3
  • 30
    • 18644373869 scopus 로고    scopus 로고
    • A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: Results of the METGO study
    • May
    • Lehman AJ, Esdaile JM, Klinkhoff AV, et al. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study. Arthritis Rheum. 2005 May;52(5):1360-70.
    • (2005) Arthritis Rheum , vol.52 , Issue.5 , pp. 1360-1370
    • Lehman, A.J.1    Esdaile, J.M.2    Klinkhoff, A.V.3
  • 31
    • 27744514865 scopus 로고    scopus 로고
    • Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (The BeSt study): A randomized, controlled trial
    • Nov
    • Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum. 2005 Nov;52(11):3381-90.
    • (2005) Arthritis Rheum , vol.52 , Issue.11 , pp. 3381-3390
    • Goekoop-Ruiterman, Y.P.1    De Vries-Bouwstra, J.K.2    Allaart, C.F.3
  • 32
    • 68049124945 scopus 로고    scopus 로고
    • Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
    • Aug
    • van Vollenhoven RF, Ernestam S, Geborek P, et al. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. Lancet. 2009 Aug 8;374(9688):459-66.
    • (2009) Lancet , vol.374 , Issue.9688 , pp. 459-466
    • Van Vollenhoven, R.F.1    Ernestam, S.2    Geborek, P.3
  • 33
    • 84865655947 scopus 로고    scopus 로고
    • A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of Early Aggressive Rheumatoid Arthritis Trial
    • Sep
    • Moreland LW, O’Dell JR, Paulus HE, et al. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum. 2012 Sep;64(9):2824-35.
    • (2012) Arthritis Rheum , vol.64 , Issue.9 , pp. 2824-2835
    • Moreland, L.W.1    O’Dell, J.R.2    Paulus, H.E.3
  • 34
    • 84880753128 scopus 로고    scopus 로고
    • Therapies for active rheumatoid arthritis after methotrexate failure
    • Jul 25
    • O’Dell JR, Mikuls TR, Taylor TH, et al. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med. 2013 Jul 25;369(4):307-18.
    • (2013) N Engl J Med , vol.369 , Issue.4 , pp. 307-318
    • O’Dell, J.R.1    Mikuls, T.R.2    Taylor, T.H.3
  • 35
    • 84877631290 scopus 로고    scopus 로고
    • Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)
    • Jun
    • Leirisalo-Repo M, Kautiainen H, Laasonen L, et al. Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). Ann Rheum Dis. 2013 Jun;72(6):851-7.
    • (2013) Ann Rheum Dis , vol.72 , Issue.6 , pp. 851-857
    • Leirisalo-Repo, M.1    Kautiainen, H.2    Laasonen, L.3
  • 36
    • 0030068817 scopus 로고    scopus 로고
    • Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria
    • Jan
    • van Gestel AM, Prevoo ML, van ‘t Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 1996 Jan;39(1):34-40.
    • (1996) Arthritis Rheum , vol.39 , Issue.1 , pp. 34-40
    • Van Gestel, A.M.1    Prevoo, M.L.2    Van ‘T Hof, M.A.3
  • 37
    • 0019407824 scopus 로고
    • Preliminary criteria for clinical remission in rheumatoid arthritis
    • Oct
    • Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 1981 Oct;24(10):1308-15.
    • (1981) Arthritis Rheum , vol.24 , Issue.10 , pp. 1308-1315
    • Pinals, R.S.1    Masi, A.T.2    Larsen, R.A.3
  • 38
    • 19944429171 scopus 로고    scopus 로고
    • Predictors of productivity loss in early rheumatoid arthritis: A 5 year follow up study
    • Jan
    • Puolakka K, Kautianen H, Möttönen T, et al. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study. Ann Rheum Dis. 2005 Jan;64(1) 130-3.
    • (2005) Ann Rheum Dis , vol.64 , Issue.1 , pp. 130-133
    • Puolakka, K.1    Kautianen, H.2    Möttönen, T.3
  • 39
    • 33846113808 scopus 로고    scopus 로고
    • Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials
    • Dec
    • Pincus T, Yazici Y, van Vollenhoven R. Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials. J Rheumatol. 2006 Dec;33(12):2372-5.
    • (2006) J Rheumatol , vol.33 , Issue.12 , pp. 2372-2375
    • Pincus, T.1    Yazici, Y.2    Van Vollenhoven, R.3
  • 40
    • 0029044362 scopus 로고
    • American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis
    • Jun
    • Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995 Jun;38(6):727-35.
    • (1995) Arthritis Rheum , vol.38 , Issue.6 , pp. 727-735
    • Felson, D.T.1    Erson, J.J.2    Boers, M.3
  • 41
    • 0029906505 scopus 로고    scopus 로고
    • Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score
    • Nov
    • Prevoo ML, van Gestel AM, van T Hof MA, et al. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol. 1996 Nov;35(11):1101-5.
    • (1996) Br J Rheumatol , vol.35 , Issue.11 , pp. 1101-1105
    • Prevoo, M.L.1    Van Gestel, A.M.2    Van T Hof, M.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.